One molecule, many mechanisms of action: Why all PD-1 inhibitors are not the same

 LECTURE   09/2020

Watch also the other lectures


1. Welcome and Introduction
Tony Mok


2. PD1 inhibitors for NSCLC: Where are we now?
Tony Mok


4. How will the new wave of PD1 inhibitors change the treatment landscape in NSCLC?
Anne-Marie C. Dingemans


5. What is the impact of PD1 inhibitors for NSCLC in your clinic? A case study discussion
Tony Mok AND Anne-Marie C. Dingemans


6. PD1 inhibitors for NSCLC: Future challenges, future potential
Giorgio Scagliotti


7. Exploring the promise of emerging PD1 inhibitors in NSCLC
Giorgio Scagliotti


Rate this resource

Nice to see you!

For newest details on our EHA materials in a personal video meeting, please click here!